The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy

MLA

Ujjani, C., et al. The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1315665797&authtype=sso&custid=ns315887.

APA

Ujjani, C., Mato, A., Hill, B., Allan, J., Lansigan, F., Jacobs, R., Skarbnik, A., Tuncer, H., Pagel, J., Brander, D., Cheson, B., Barr, P., Roeker, L., Pu, J., Shah, N., Goy, A., Schuster, S., Lamanna, N., Sehgal, A., … Shadman, M. (2020). The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy.

Chicago

Ujjani, C, A Mato, Bt Hill, Jn Allan, F Lansigan, R Jacobs, A Skarbnik, et al. 2020. “The Impact of Age on Survival in CLL Patients Receiving Ibrutinib as Initial Therapy.” http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsoai&AN=edsoai.on1315665797&authtype=sso&custid=ns315887.